Cytotoxic activity of methanol extracts from Basidiomycete mushrooms on murine cancer cell lines

Pharmazie

Volumn 59, Issue 4, 2004, Pages 290-293

  Tomasi, Sophie ^a,b   Lohezic Le Devehat, F ^a   Sauleau, P ^a   Bezivin C ^a   Boustie, J ^a  

^a UPRES 2234   (France)

^b Institute de Chimie de'Rennes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BOLETUS EDULIS EXTRACT; CANTHARELLUS TUBIFORMIS EXTRACT; DAEDALEOPSIS CONFRAGOSA EXTRACT; GANODERMA LUCIDUM EXTRACT; GYMNOPILUS SPECTABILIS EXTRACT; LACTARIUS QUIETUS EXTRACT; MERIPILUS GIGANTEUS EXTRACT; METHANOL; OLIGOPORUS STYPICUS EXTRACT; PIPTOPORUS BETULINUS EXTRACT; STROBILOMYCES STROBILACEUS EXTRACT; SUILLUS BOVINUS EXTRACT; SUILLUS GRANULATUS EXTRACT; SUILLUS LUTEUS EXTRACT; TETRAZOLIUM; TRAMETES VERSICOLOR EXTRACT; TYLOPILUS FELLEUS EXTRACT; UNCLASSIFIED DRUG;

AMANITA PHALLOIDES; ANIMAL CELL; ARTICLE; BASIDIOMYCETES; BOLETUS EDULIS; CANCER INHIBITION; CANTHARELLUS TUBIFORMIS; CONTROLLED STUDY; CYTOTOXICITY; DAEDALEOPSIS CONFRAGOSA; DRUG ISOLATION; GANODERMA LUCIDUM; GYMNOPILUS SPECTABILIS; IC 50; IN VITRO STUDY; INHIBITION KINETICS; LACTARIUS QUIETUS; MERIPULUS GIGANTEUS; MUSHROOM; NONHUMAN; OLIGOPORUS STYPTICUS; PIPTOPORUS BETULINUS; SPECIES COMPARISON; STROBILOMYCES STROBILACEUS; SUILLUS GRANULATUS; SUILLUS LUTEUS; TAXUS BACCATA; TRAMETES VERSICOLOR; TYLOPILUS FELLEUS;

ANIMALS; ANTINEOPLASTIC AGENTS; BASIDIOMYCOTA; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; INDICATORS AND REAGENTS; LEUKEMIA L1210; METHANOL; MICE; NITROBLUE TETRAZOLIUM; SOLVENTS;

EID: 1842683161     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Anke H, Hillen-Maske E, Steglich W (1989a) 9β-Hydroxymarasmic acid and other sesquiterpenoids from submerged cultures of a Basidiomycete. Zschr Naturforsch 44c: 1-6.
2. Anke H, Bergendorff O, Sterner O (1989b) Assays of the biological activities of guaiane sesquiterpenoids isolated from the fruit bodies of edible Lactarius vellereus. Food Chem Toxicol 27: 393-397.
3. Anke H, Sterner O (1991) Comparison of the antimicrobial and cytotoxic activities of twenty unsaturated sesquiterpene dialdehydes from plants and mushrooms. Planta Med 57: 344-346.
4. Anke H, Morales P, Sterner O (1996) Assays of the biological activities of two fatty acid derivatives formed in the edible mushrooms Cantharellus cibarius and C. tubaeformis as a response to injury. Planta Med 62: 181-183.
5. Bao XF, Wang XS, Dong Q, Fang JN, Li XY (2002) Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry 59: 175-181.
6. Bézivin C, Lohézic F, Sauleau P, Amoros M, Boustie J (2002) Cytotoxic activity of Tricholomatales with murine and human cancer cell lines. Pharm Biol 40: 196-199.
7. Bézivin C, Tomasi S, Lohézic-Le Dévéhat F, Boustie J (2003) Cytotoxic activity of some lichen extracts on murine and human cancer cell lines. Phytomedicine 10: 499-503.
8. Chang R (1996) Functional properties of edible mushrooms. Nutrition Rev 54: S91-S93.
9. Christov GD, Vassilev VI, Panov PP (1974) Activité antitumorale de champignons comestibles indigènes. Comp Rend Acad Bulg Sci 27: 1309-1311.
10. Cordell GA, Kinghorn D, Pezzuto JM (1993) Separation, structure elucidation, and bioassay of cytotoxic natural products. In: Bio Nat Prod CRC Press, Boca Raton, p. 195-216.
11. Courtecuisse R, Duhem B (2000) Guide des champignons de France et d'Europe. In, Delachaux et Niestlé, Lausanne, p. 476.
12. Czarnecki R, Crzybek J (1995) Antiinflammatory and vasoprotective activities of polysaccharides isolated from fruit bodies of higher fungi p.1. Polysaccharides; from Trametes gibbosa (Pers.: Fr)Fr. (Polyporaceae). Phytother Res 9: 123-127.
13. Faulstich H, Cochet-Meilhac M (1976) Amatoxins in edible mushrooms. FEBS Lett 61: 73-75.
14. Gao, JJ, Min BS, Ahn EM, Nakamura N, Lee HK, Hattori M (2002) New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem Pharm Bull 50: 837-840.
15. Hamburger M, Handa SS, Cordell GA, Kinghom DA, Farnsworth NR (1987) Plant anticancer agents, XLIII. (E,E)-7,12-dioxo-octadeca-8,10-dien-1-oic acid (ostopanic acid), a cytotoxic fatty acid from Ostodes paniculata. J Nat Prod 50: 281-283.
16. Hu H, Ahn NS, Yang X, Lee YS, Kang KS (2002) Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 breast cancer cell. Int J Cancer 102: 250-253.
17. Jonassohn M, Hjertberg R, Anke H, Dekermendjian K, Szallasi A, Thines E, Witt R, Sterner O (1997) The preparation and bioactivities of (-)-Isovelleral. Bioorg Med Chem 5: 1363-1367.
18. Jong SC, Donovick R (1989) Antitumor and antiviral substances from fungi. Adv Appl Microbiol 34: 183-262.
19. Jong SC, Birmingham JM, Pai SH (1991) Immunomodulatory substances of fungal origin. J Immunol Immunopharmacol XI: 115-122.
20. Kahlos K, Kangas L, Hiltunen R (1989) Ergosterol peroxide, an active compound from Inonotus radiatus. Planta Med 55: 389-390.
21. Kim HW, Kim BK (1999) Biomedicinal triterpenoids of Ganoderma lucidum (Curt.:Fr.) P. Karst. (Aphyllophoromycetideae). Int J Med Mushrooms 1: 121-138.
22. 4 leukemic cancer cells, HeLa cervical cancer cells. J Herbs Spices Med Plants 6: 49-57.
23. Lucas EH, Ringler RL, Byerrum RU, Stevens JA, Clarke DA, Stock CC (1957) Tumor inhibitors in Boletus edulis and other holobasidiomycetes. Antibiot Chemother VII: 1-4.
24. Maniglia CA, Wilson RG (1979) Purification and properties of RNA polymerase II from mouse leukemia L1210 ascites cells. Int J Biochem 10: 739-744.
25. Min BS, Gao JJ, Nakamura N, Hattori M (2000) Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against Meth-A and LLC tumor cells. Chem Pharm Bull 48: 1026-1033.
26. Min BS, Lee HK, Bae KH, Gao JJ, Nakamura N, Hattori M (2002) Antitumor activity of cultured mycelia of Ganoderma lucidum. Nat Prod Sci 8: 52-54.
27. Miyazaki T, Nishijima M (1981) Studies on fungal polysaccharides XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull 29: 3611-3616.
28. Mizuno T, Saito H, Nishitoba T, Kawagishi H (1995) Antitumor-active substances from mushrooms. Food Rev Int 11: 23-61.
29. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55-63.
30. Nam KS, Jo YS, Kim YH, Hyun JW, Kim HW (2001) Cytotoxic activities of acetoxyscirpenediol and ergosterol peroxide from Paecilomyces tenuipes. Life Sci 69: 229-237.
31. Nano GM, Binello A, Bianco MA, Ugazio G, Burdino S (2002) In vitro tests to evaluate potential biological activity in natural substances. Fitoterapia 73: 140-146.
32. Narbe G, Lindequist U, Teuscher E, Franke P, Vainiotalo P, Basner R (1991) Studies of the chemistry of immunosuppressive active fractions from Meripilus giganteus (PERS. ex. FR.) KARST. Pharmazie 46: 738-740.
33. Nunez-Alarcon J, Carlos Paredes JC, Carmona MT, Quinones M (2001) Ostopanic acid, a cytotoxic fatty acid from Gymnopilus spectabilis. Bol Soc Chil Quim 46: 227-229.
34. Park SS, Lee KD, Min TJ (1995) Study of the screening and development of antibiotics in the mushrooms. The screening for bacterial and fungal antibiotics in Basidiomycetes (II). Han'guk Kyunhakhoechi 23: 176-189.
35. Porte M, Villard J, Oddoux L (1982) Recherche d'une activité antitumorale dans le filtrat de culture de Basidiomycètes. Annal Pharm Franc 40: 147-152.
36. Quack W, Anke T, Oberwinkler F, Giannetti BM, W. S (1978) Antibiotics from Basidiomycetes. V. Merulidial, a new antibiotic from the Basidiomycete Merulius tremellosus Fr. J Antib XXXI: 737-741.
37. Shibata S, Nishikawa Y, Cheng FM, Fukuoka F, Nakanishi M (1968) Antitumor studies on some extracts of Basidiomycetes. Gann 59: 159-161.
38. Sone Y, Okuda R, Wada N, Kishida E, Misaki A (1985) Structures and antitumor activities of the polysaccharides isolated from the fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agricult Biol Chem 49: 2641-2653.
39. Sterner O, Bergman R, Kihlberg J, Wickberg B (1985) The sesquiterpenes of Lactarius vellereus and their role in a proposed chemical defense system. J Nat Prod 48: 279-288.
40. Sterner O (1995) Toxic terpenoids from higher fungi and their possible role in chemical defence sytems. Cryptogam Mycol 16: 47-57.
41. Tringali C, Geraci C, Nicolosi G, Verbist JF, Roussakis C (1989) An antitumor principle from Suillus granulatus. J Nat Prod 52: 844-845.
42. Wang S, Hsu M, Hsu H, Tzeng C, Lee C, Shiao M, Ho C (1997) The antitumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 70: 699-705.
43. Wasser S, Weis A (1997) Medicinal mushrooms, Ganoderma lucidum (Curtis: Fr.) P. Karst., Reishi mushroom. In, Pedelfus Publishing House, Haifa, p. 39.
44. Wasser S, Weis A (1999) Therapeutic effects of substances occuring in higher basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 19: 65-96.
45. Wasser S (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60: 258-274.
46. Wu T, Shi L, Kuo S (2001) Cytotoxicity of Ganoderma lucidum triterpenes. J Nat Prod 64: 1121-1122.
47. Yun BS, Kang HC, Koshino H, Yu SH, Yoo ID (2001) Suillusin, a unique benzofuran from the mushroom Suillus granulatus. J Nat Prod 61: 1230-1231.
48. Zhu HS, Yang XL, Wang LB, Zhao DX (2000) Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells. Cell Biol Toxicol 16: 201-206.